Literature DB >> 11896614

p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma.

Georgina Platt1, Antonino Carbone, Sibylle Mittnacht.   

Abstract

The Kaposi's Sarcoma associated Herpes virus (KSHV) encodes two genes with the potential to affect the activity of the retinoblastoma protein (Rb). Open reading frame (orf) 72 encodes a D type cyclin (kcyc) that can elicit p16INK4a resistant cdk activity and orf73 encodes the latency associated nuclear antigen (LNA) that can bind Rb and neutralize E2F regulation. This indicates that, like papilloma and adenovirus associated malignancies, those associated with KSHV are defective with respect to their Rb pathway. To address this we investigated whether KSHV associated primary effusion lymphoma (PEL) derived cell lines are resistant to growth inhibition by p16INK4a. We provide evidence that ectopic expression of p16INK4a in these cells causes an Rb dependent G1 cell cycle block. Importantly, endogenous p16INK4a expression is not detected in six PEL derived cell lines and four primary PEL samples and examination of the p16INK4a locus shows deletion in two out of six and hypermethylation in four out of six PEL lines. Treatment of the latter with the demethylating agent 5'-aza-2' deoxycytidine leads to re-expression of p16INK4a protein. Taken together these results suggest that p16INK4a loss may be a cellular change frequently associated with PEL. They furthermore argue that despite the presence of KSHV DNA and expression of a latent gene program Rb function is intact in PEL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896614     DOI: 10.1038/sj.onc.1205360

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiqiang Qin; Lu Dai; Bryan Toole; Erle Robertson; Chris Parsons
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

Authors:  Mark Cannon; Ethel Cesarman; Chris Boshoff
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 3.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

Review 4.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

5.  A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest.

Authors:  Eva Gottwein; Bryan R Cullen
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 6.  Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses.

Authors:  Abhik Saha; Erle S Robertson
Journal:  FEBS Lett       Date:  2011-08-11       Impact factor: 4.124

7.  Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma.

Authors:  Emmanuelle Boulanger; Agnès Marchio; Saw-See Hong; Pascal Pineau
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

8.  Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells.

Authors:  Hongyi Pan; Fuchun Zhou; Shou-Jiang Gao
Journal:  Cancer Res       Date:  2004-06-15       Impact factor: 12.701

9.  Modulation of Cellular CpG DNA Methylation by Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Guy Journo; Carmel Tushinsky; Asia Shterngas; Nir Avital; Yonatan Eran; Marcela Viviana Karpuj; Milana Frenkel-Morgenstern; Meir Shamay
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

Review 10.  Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?

Authors:  Patrick S Moore; Yuan Chang
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.